Lexeo Therapeutics (LXEO) Return on Sales: 2023

Historic Return on Sales for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to 323.87%.

  • Lexeo Therapeutics' Return on Sales was N/A to 323.87% in Q4 2023 from the same period last year, while for Dec 2023 it was 323.87%, marking a year-over-year change of. This contributed to the annual value of 717.76% for FY2024, which is 39389.00% up from last year.
  • Lexeo Therapeutics' Return on Sales amounted to 323.87% in Q4 2023, which was up 1.36% from 319.54% recorded in Q3 2023.
  • Lexeo Therapeutics' Return on Sales' 5-year high stood at 323.87% during Q4 2023, with a 5-year trough of -170.40% in Q2 2023.
  • Its 1-year average for Return on Sales is 157.67%, with a median of 319.54% in 2023.